Metals in our minds: therapeutic implications for neurodegenerative disorders (Q35811065)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on July 2004

Language	Label	Description	Also known as
English	Metals in our minds: therapeutic implications for neurodegenerative disorders	scientific article published on July 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

Metals in our minds: therapeutic implications for neurodegenerative disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

neurodegeneration

1 reference

based on heuristic

inferred from title

author name string

P Murali Doraiswamy

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Anne E Finefrock

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

431-434

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of metals as therapeutic targets in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of antioxidant therapy for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron and Parkinson's Disease: Chelators to the Rescue?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The yeast frataxin homologue mediates mitochondrial iron efflux. Evidence for a mitochondrial iron cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron pigment in the brain of a man with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron metabolism and mitochondrial abnormalities in Friedreich ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The metallobiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo reduction of amyloid-beta by a mutant copper transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Metal chelation as a potential therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Alzheimer's disease with clioquinol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clioquinol's return: cautions from Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

[Aetiological and clinical study on subacute myelo-optico-neuropathy (SMON) (author's transl)].

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Generate Hydrogen Peroxide and Promote α-Crystallin Cross-Linking by Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Metals and neuroscience.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900809-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(04)00809-9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35811065&oldid=1598280108"